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Mycobacterium avium is an important pathogen among immunodefi-
cient patients, especially patients with AIDS. The natural history of
this disease is unclear. Several environmental sources have been
implicated as the origin of this infection. Polyclonal infection with this
species is observed, challenging the understanding of its pathogenesis
and treatment. In the present study 45 M. avium strains were recovered
from 39 patients admitted to a reference hospital between 1996 and
1998. Species identification was performed using a species-specific
nucleic acid hybridization test (AccuProbe®) from Gen-Probe®. Strains
were genotyped using IS1245 restriction fragment length polymor-
phism typing. Blood was the main source of the organism. In one
patient with disseminated disease, M. avium could be recovered more
than once from potentially sterile sites. Strains isolated from this
patient had different genotypes, indicating that the infection was
polyclonal. Four patient clones were characterized in this population,
the largest clone being detected in eight patients. This finding points to
a common-source transmission of the organism.
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Mycobacterium avium has emerged as a
frequent pathogen among immunodeficient
patients since the advent of AIDS (1). Al-
though antiretroviral treatment has had a
significant impact on the course of this dis-
ease (2), cases of M. avium infection still
have a poor prognosis (3-5). The natural
history of the disease has not been deter-
mined. It seems that the environment itself,
including animal reservoirs more than hu-
mans, represents the natural source of bacte-
ria for these patients (6,7). Disseminated
disease is observed in AIDS patients, as evi-
denced by blood, bone marrow and deep
tissue cultures (4,8-10). Polyclonal infection
has been documented and seems to be fre-
quent (11,12).
Molecular typing techniques are impor-
tant tools to determine the epidemiology of
infectious diseases. Several methods based
on amplification, hybridization or restriction
can be applied to trace the mechanisms of
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disease. DNA fragment restriction and sub-
sequent hybridization with IS1245 probes
have been shown to be suitable for typing M.
avium infections (13,14).
The AIDS epidemic is a serious health
problem. Infections caused by mycobacte-
ria, mainly M. tuberculosis and M. avium,
are frequently seen at our hospital. M. avium
was identified in 45% of HIV-infected pa-
tients with mycobacterial diseases during
the year 1996 (8).
The present study was designed to iden-
tify and characterize the genetic polymor-
phism of M. avium strains recovered from
clinical specimens between 1996 and 1998.
Material and Methods
Setting
The study was performed at the Hospital
de Clínicas, Universidade Estadual de Cam-
pinas (HC-UNICAMP), Campinas, SP, Bra-
zil. The hospital serves an area with an esti-
mated population of 5 million people. All
cultures positive for M. avium from 1996
through 1998 were analyzed.
Isolation and identification of mycobacteria
Primary isolation was performed under
safety conditions in the Mycobacterial Labo-
ratory. The isolates were cultivated in 12-B
and 13-B bottles of the BACTEC 460TB
radiometric culture system (Becton Dickin-
son® Microbiology Systems, Sparks, MD,
USA). Aliquots from positive bottles were
transferred to Lowenstein-Jensen (LJ) medi-
um. Mycobacteria were identified on fully
grown LJ slants. Species identification was
performed with the AccuProbe® M. avium
complex Culture Identification Test (Gen-
Probe® Incorporated, San Diego, CA, USA).
Molecular strain typing
IS1245 restriction fragment length poly-
morphism (RFLP) was determined accord-
ing to an internationally standardized proto-
col (14). Fingerprints were analyzed visually
and considered to be identical when all bands
shared the same molecular weight positions.
M. avium reference strain IWGMT49 with
fragments of known molecular weights was
analyzed together with unknown samples.
Results
Forty-five M. avium isolates were recov-
ered from a variety of clinical specimens
from 39 patients (Table 1). Almost all the
patients included in the study (N = 35) had
documented HIV infection. Forty-three iso-
lates could be typed with the IS1245 RFLP,
while two strains were untypable because of
the absence of detectable IS1245 copies. M.
avium was recovered from blood, bone mar-
row, biopsy tissue or cerebrospinal fluid
(CSF) in 47% of samples, with blood cul-
Table 1. Mycobacterium avium recovered from 39
patients during the 1996-1998 period.





Liver biopsy 3 (6.7)
Bone marrow 3 (6.7)
Gastric lavage 1 (2.2)
Cerebrospinal fluid 1 (2.2)
Broncho-alveolar lavage 1 (2.2)
Skin 1 (2.2)
Total 45
Table 2. Sources of clinical specimens, number of
IS1245 bands observed, and date of recovery of
isolates from a patient with polyclonal and dis-
seminated Mycobacterium avium infection.
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Figure 1. IS1245 fingerprints of
Mycobacterium avium isolated
from a patient with multiple
strains recovered. Lanes 1 and
2, Isolates from two blood
samples; lane 3, isolate from
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Figure 2. Number of isolates ac-
cording to the number of IS1245
bands observed. Clustered
strains are outlined and repre-
sent one strain per patient.
tures being the main source of the organism.
The RFLP patterns of the 43 typable
strains consisted of 6 to 23 bands with an
average of 17 IS1245 copies per strain. For
five patients, more than one isolate could be
recovered. In one patient with disseminated
disease, two strains with different genotypes
were recovered from blood cultures drawn
one week apart (Table 2), indicating that he
had a polyclonal infection (fingerprints
shown in Figure 1). Fingerprinting studies
also showed that 16 of 39 patients (41%)
could be assigned to four IS1245 clusters.
The individual clusters and the distribution
of isolates according to the number of IS1245
copies observed are shown in Figure 2. The
largest cluster, arbitrarily designated MA18,
consisted of eight patients. Some fingerprints
of selected isolates belonging to this cluster
are shown in Figure 3.
Discussion
Mycobacterium avium infections are fre-
quently detected in AIDS patients in Brazil
despite the wide use of highly active anti-
retroviral chemotherapy (4,9). This infec-
tion has been associated with AIDS in the
presence of the late immunosuppression that
occurs when CD4+ cell counts are extremely
low. Antiretroviral treatment has consider-
ably improved the prognosis of AIDS by
reducing the incidence of opportunistic
events, but treatment failures, and non-ad-
herence to therapy render individuals sus-
ceptible to many pathogens. In such patients
M. avium has been isolated from many clini-
cal sources, including stool, sputum, skin,
blood, CSF, and biopsy tissues. Isolation of
organisms from these body sites does not
necessarily mean that they are a cause of
morbidity, unless they are found at sterile
sites concomitantly with clinical evidence
such as anemia, weight loss and diarrhea
(4,9). The epidemiological events involved
in the natural history of this infection have
not yet been clarified.
Blood was the main source of M. avium
in our study population, as also reported by
others (5,8), and confirms the disseminated
character of this infection (4). Oplustil et al.
(4) have shown that the M. avium complex
was recovered from 58.4% of positive vials,
corresponding to 53.6% of patients with posi-
tive blood cultures.
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Our study also shows that 41% of the
strains recovered from several clinical speci-
mens were in clusters, indicating that these
strains were acquired from common sources
of infection. However, these sources of in-
fection could not be determined in the pres-
ent investigation. Since M. avium is not trans-
1 2 3 4 5 6
Figure 3. Some fingerprints from
the largest cluster found, and
arbitrarilly designated MA18.
mitted from human to human we suspect that
the patients acquired the organism from the
hospital environment, probably from water
or food. In a recent study (15), it was con-
cluded that M. avium complex infection re-
sults from diverse and probably undetect-
able environmental and nosocomial expo-
sure.
Polyclonal infection was demonstrated
in one patient in our study. This has been
reported previously (12) and it has also been
shown that organisms isolated from polyclo-
nal infections demonstrated by organisms
with different fingerprints can have different
antimicrobial susceptibility (11).
Improved strategies to facilitate identifi-
cation of HIV-infected people encourage
patient enrollment in clinical care, and im-
prove adherence to prevention. However,
new treatment regimens will be needed be-
fore disseminated M. avium complex dis-
ease can be effectively prevented.
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